- $3.25bn
- $2.95bn
- $631.10m
Figs Inc reports results for the quarter ended in December - Earnings Summary
Brief: Figs Releases Fourth Quarter And Full Year 2022 Financial Results
Figs Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: FIGS Says Strategic Partners and Co have settled all litigation brought by SPI against FIGS
Brief: Statement By Careismatic Brands, Inc. Regarding Settlement Of Litigation With Figs, Inc
U.S. RESEARCH ROUNDUP-Evoqua Water Technologies, Taysha Gene Therapies, Veradigm
U.S. RESEARCH ROUNDUP-Evoqua Water Technologies, Taysha Gene Therapies, Veradigm
NYSE ORDER IMBALANCE 72646.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 153233.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 63858.0 SHARES ON SELL SIDE
Figs falls on FY 2022 revenue forecast cut
Figs Inc reports results for the quarter ended in September - Earnings Summary
Brief: Figs Releases Third Quarter 2022 Financial Results
Figs Inc expected to post earnings of 2cents a share - Earnings Preview
NYSE ORDER IMBALANCE 96715.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP-BlackRock, Emerson, Infosys
NYSE ORDER IMBALANCE 70802.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 57032.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 60915.0 SHARES ON SELL SIDE